CSIMarket
 
Zivo Bioscience Inc   (ZIVO)
Other Ticker:  
 
 
Price: $17.8000 $-0.10 -0.559%
Day's High: $17.8 Week Perf: -7.53 %
Day's Low: $ 17.80 30 Day Perf: -16.2 %
Volume (M): 0 52 Wk High: $ 22.15
Volume (M$): $ 2 52 Wk Avg: $14.83
Open: $17.80 52 Wk Low: $3.13



 Market Capitalization (Millions $) 61
 Shares Outstanding (Millions) 3
 Employees 2
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -14
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

Zivo Bioscience Inc
We were incorporated under the laws of the State of Nevada on March 28, 1983, under the name of “L. Peck Enterprises, Inc.” On May 27, 1999, we changed our name to “Western Glory Hole, Inc.” From 1990 until October 2003, we had no business operations; we were in the development stage and were seeking profitable business opportunities. On October 30, 2003, we acquired 100% of the outstanding shares of Health Enhancement Corporation (“HEC”) in exchange for 9,000,000 of our shares, making HEC our wholly-owned subsidiary. In connection with this transaction, we changed our name to Health Enhancement Products, Inc. On October 14, 2014, at the annual meeting of the Shareholders of the Company, a proposal was passed to change the name of the Company from Health Enhancement Products, Inc. to Zivo Bioscience, Inc. (“ZIVO”). On October 30, 2014, the Financial Industry Regulatory Authority (“FINRA”) approved the name Zivo Bioscience, Inc. for trading purposes and the symbol change to ZIVO effective November 10, 2014.


   Company Address: 21 East Long Lake Road Bloomfield Hills 48304 MI
   Company Phone Number: 452-9866   Stock Exchange / Ticker: ZIVO


Customers Net Income grew by ZIVO's Customers Net Profit Margin grew to

921.22 %

10.93 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABT   -3.07%    
BMY        0.1% 
DD        2.48% 
HRL        2.43% 
JNJ        0.83% 
PFE        2.39% 
• View Complete Report
   



Business Update

ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza

Published Fri, Dec 20 2024 6:50 PM UTC

ZIVO Bioscience: Harnessing Algal Innovations to Combat Avian Influenza amid Financial ChallengesIn an exciting development in biotechnology and agricultural technology, ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering company in developing therapeutic and nutritional products derived from proprietary algal cultures, has reported promising preliminary results in using its ...

Business Update

ZIVO Bioscience Secures Breakthrough in Coccidiosis Treatment for Poultry with Promising Study Resu...

Published Mon, Aug 26 2024 8:44 AM UTC

ZIVO Bioscience Achieves Promising Results in Coccidiosis Treatment for Broiler Chickens In an era where sustainable and responsible farming practices are paramount, ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech and agtech research and development company, has announced positive outcomes from its recently conducted 42-day confirmatory study on a novel coccidiosis...

Business Update

Augmenting Poultry Health ZIVO Biosciences Breakthrough Non-Antibiotic Treatment for Coccidiosis,

Published Sat, Aug 24 2024 7:17 AM UTC

ZIVO Biosciences: Pioneering Non-Antibiotic Solutions for Poultry Health In the intricate world of agricultural biotechnology, breakthroughs in animal health can usher in revolutionary changes that ripple across the entire industry. One such pioneering company, ZIVO Biosciences, Inc., is staking its claim as a trailblazer in this field. Based in Bloomfield Hills, Michigan, Z...

Business Update

ZIVO Bioscience Pioneering Poultry Health Amid Financial Flux,

Published Fri, Aug 23 2024 6:09 PM UTC

ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company, recently reported highly favorable results from a 42-day study targeting coccidiosis in broiler chickens. This study, conducted with a major global animal health company, mirrors real-world poultry production environments, indicating promising commercial potential for ZIVO s coccidiosis treatment. ...

Business Update

ZIVO Bioscience and Major Global Animal Health Company Team Up for Groundbreaking Study on Coccidiosis Treatment ...

Published Mon, Jul 8 2024 12:47 PM UTC

Major Global Animal Health Company Collaborates with ZIVO Biosciences for Coccidiosis StudyBLOOMFIELD HILLS, Mich. ZIVO Bioscience, Inc. (NASDAQ: ZIVO), a leading biotech/agtech R&D company focused on developing therapeutic, medicinal, and nutritional products derived from proprietary algal cultures, has announced the commencement of a 42-day confirmatory study in partners...







Zivo Bioscience Inc's Segments





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com